Existing studies have fully proved that ATAD3A has a high tumor marker value, but the correlation between its expression level and clinicopathology of bladder cancer is not very clear, and the corresponding research reports are missing. The gene discussed is ATAD3A; the disease is urinary bladder carcinoma.